Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells VF Chekhun, GI Kulik, OV Yurchenko, VP Tryndyak, IN Todor, LS Luniv, ... Cancer letters 231 (1), 87-93, 2006 | 105 | 2006 |
Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity S Daum, VF Chekhun, IN Todor, NY Lukianova, YV Shvets, L Sellner, ... Journal of medicinal chemistry 58 (4), 2015-2024, 2015 | 80 | 2015 |
The lipid content of cisplatin-and doxorubicin-resistant MCF-7 human breast cancer cells IN Todor, NY Lukianova, VF Chekhun Experimental oncology, 2012 | 77 | 2012 |
Gold nanoparticles synthesis and biological activity estimation in vitro and in vivo LS Rieznichenko, SM Dybkova, TG Gruzina, ZR Ulberg, IN Todor, ... Experimental Oncology, 2012 | 35 | 2012 |
Changes in VEGF level and tumor growth characteristics during Lewis lung carcinoma progression towards cis-DDP resistance ON Pyaskovskaya, OI Dasyukevich, DL Kolesnik, LV Garmanchouk, ... Experimental oncology, 2007 | 35 | 2007 |
Structural organisation of nucleic acids from tumour cells OP Repnytska, GI Dovbeshko, VP Tryndiak, IM Todor, DV Kosenkov Faraday discussions 126, 61-76, 2004 | 27 | 2004 |
Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor OO Shevchuk, KA Posokhova, IN Todor, NY Lukianova, VG Nikolaev, ... Experimental oncology, 135-138, 2015 | 21 | 2015 |
Green tea, red wine and lemon extracts reduce experimental tumor growth and cancer drug toxicity S Zaletok, L Gulua, L Wicker, V Shlyakhovenko, S Gogol, O Orlovsky, ... Experimental oncology, 2015 | 20 | 2015 |
Анализ силового воздействия высокоградиентного магнитного поля на магнитные наночастицы в потоке жидкости АВ Кириленко, ВФ Чехун, АД Подольцев, ИП Кондратенко, ... Доповіді НАН України, 2010 | 19 | 2010 |
The SEIRA spectroscopy data of nucleic acids and phospholipids from sensitive-and drug-resistant rat tumours. VF Chekhun, GI Solyanik, GI Kulik, VP Tryndiak, IN Todor, GI Dovbeshko, ... Journal of Experimental & Clinical Cancer Research: CR 21 (4), 599-607, 2002 | 19 | 2002 |
Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma D Horak, VI Pustovyy, AV Babinskyi, OM Palyvoda, VF Chekhun, IN Todor, ... International Journal of Nanomedicine, 4257-4268, 2017 | 18 | 2017 |
Липосомальные препараты: путь к преодолению лекарственной устойчивости к цисплатину ГИ Кулик, ВМ Пивнюк, ММ Носко, ИН Тодор, ВФ Чехун Iнститут експериментальної патології, онкології і радіобіології ім. РЄ …, 2009 | 17 | 2009 |
Colloidally stable surface-modified iron oxide nanoparticles: Preparation, characterization and anti-tumor activity H Macková, D Horák, GV Donchenko, VI Andriyaka, OM Palyvoda, ... Journal of Magnetism and Magnetic Materials 380, 125-131, 2015 | 14 | 2015 |
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin IN Todor, NY Lukianova, YV Shvets, YV Lozovska, VF Chekhun Experimental oncology, 2015 | 14 | 2015 |
Resistance of Guerin's carcinoma cells to cisplatine: Biochemical and morphological aspects OV Yurchenko, IN Todor, VP Tryndyak, NA Tregubova, OV Kovtonyuk, ... Экспериментальная онкология 25 (1), 64-68, 2003 | 14 | 2003 |
Structural alterations of plasma membranes of Guerin’s carcinoma cells upon the development of resistance to doxorubicine РК ДОКСОРУБИЦИНУ Experimental Oncology 24, 279-283, 2002 | 14 | 2002 |
Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles OV Yurchenko, IN Todor, IK Khayetsky, NA Tregubova, NY Lukianova, ... Experimental Oncology, 2010 | 13 | 2010 |
Total proteolytic activity and levels of the main proteinase inhibitors in blood plasma of mice bearing Lewis lung carcinoma upon development of resistance to cisplatin. VF Chekhun, OV Kovtonyuk, IN Todor, GI Kulik Experimental Oncology 27 (4), 286-289, 2005 | 13 | 2005 |
Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin LA Naleskina, IN Todor, MM Nosko, NY Lukianova, VM Pivnyuk, ... Experimental oncology, 192-197, 2013 | 12 | 2013 |
The use of nanoferromagnetics to increase the cytotoxic effect of antitumor drugs VF Chekhun, IN Todor, NY Lukyanova, SI Shpyleva, LA Naleskina, ... Experimental Oncology, 2009 | 12 | 2009 |